Studies evaluating the role of IL-4 in PD pathology are limited; however, recombinant IL-4 prevents LPS-induced microglial activation in vitro [113], and IL-4 knockout mice have enhanced microglial activation in response to LPS in vivo [114]. The gene discussed is IL4; the disease is Parkinson disease.